Cinvige's Brand Renewal & New Product Launch Conference Comes to a Successful Close
On June 15, 2026, Cinvige Medical successfully held its Brand Renewal & New Product Launch Conference under the theme "Gathering Core Strength, Accelerating a New Chapter." The event marked a comprehensive upgrade of Cinvige's visual identity, brand essence, and business strategy. Reinvigorated, Cinvige will now focus exclusively on the premium drug delivery device sector, leveraging rapid product development and efficient manufacturing capabilities to bridge the entire chain from concept to commercialization, embarking on a new journey.
Brand Renewal: A Strategic Leap from "GanGan" to "Cinvige"
At the conference, Mr. Zhang Hongdao, CEO of Cinvige Medical, delivered a keynote speech, offering an in-depth interpretation of the brand renewal strategy and the company's future development blueprint. He noted that global precision drug delivery technologies are rapidly evolving, the biologics market continues to expand, and clinical settings are imposing higher demands on safety, user compliance, and intelligence levels of drug delivery devices—traditional equipment can no longer meet the trends and urgent clinical needs of today's healthcare industry.
Facing these challenges, Cinvige Medical has clarified its brand mission and future direction. Mr. Zhang Hongdao emphasized: "Our mission is to enhance patients' quality of life with safe, simple and human-centric precision drug delivery devices. “This is not only the starting point of our product design but also Cinvige's commitment to every patient.
Driven by this mission, the company has established a clear development vision: We deliver full-process support and services from concept to commercialization with rapid and effective product development, as well as efficient and leading manufacturing capabilities. We strive to be an innovative leader in drug delivery device solutions and a trusted, preferred partner for global pharmaceutical enterprises.
This brand renewal is not merely a visual facelift, but a strategic advancement grounded in Cinvige's heritage and oriented toward long-term growth. Going forward, Cinvige will concentrate its core resources on deeply cultivating the entire value chain of R&D, manufacturing, and sales in premium drug delivery devices, tackling technical challenges in the niche segment, and striving to become a leading enterprise in the premium drug delivery device arena.
At the conference, Mr. Zhang Hongdao (CEO of Cinvige Medical), Mr. Zhang Hao (Executive Director of Hillhouse Investment), Ms. Li Jing (Vice President of Huiyu Pharmaceutical Packaging Technology Research Institute), Mr. Chen Quanmin (Vice President of Global Formulation Product Business Unit at WuXi Biologics Shanghai), Mr. Yang Bin (Certification Officer of TÜV Rheinland), and Mr. Tian Shuo (Human Factors Engineer at Gan & Lee Pharmaceuticals) jointly took the stage to launch the Cinvige Medical brand, marking the official commencement of a new growth cycle driven by the brand as its core engine.
Blockbuster New Product Debut: Disposable Spring-driven Cartridge Pen Injector
The most anticipated segment of the conference was the blockbuster debut of Cinvige's newly self-developed core product—the Disposable Spring-driven Cartridge Pen Injector. With breakthrough technological innovation, it fills a critical market gap and injects new momentum into industry channel development. This is a single-use, dose-adjustable, accurate and stable smart drug delivery system. Building on the safety advantages of traditional prefilled products, it achieves a comprehensive innovation in injection mechanism:
Precise Dosing – A stable and controllable spring-driven mechanism ensures consistent accuracy with every injection.
Ultra-Simple Operation – Innovatively eliminates the barrel extension structure and adds automatic drug delivery after activation, simplifying the procedure and lowering the learning curve.
Safe & Reliable – Effectively prevents operational errors, delivering a more convenient and safer precision dosing experience for healthcare professionals and patients alike.
As a full-chain solution provider focused on premium drug delivery devices, Cinvige's product portfolio goes far beyond this. Leveraging years of technical accumulation and manufacturing strengths, the company has built a comprehensive product matrix covering diverse dosing scenarios, including reusable pen injectors, prefilled cartridge pen injector components, auto-injector components, and disposable pen needles—a full range of premium delivery products that fully address diverse clinical needs from chronic disease long-term management to acute self-administration.
The successful conclusion of this conference is not only a comprehensive showcase of Cinvige Medical, but also a significant milestone in the collaborative development of the brand and its channel ecosystem. Looking ahead, Cinvige Medical will continue to take technological innovation as its core engine, offering more competitive products, enhanced service support, and greater market returns. We will deeply bind with all partners and jointly cultivate the blue ocean of the premium drug delivery device market, enhancing patients' quality of life through safe, simple, and human-centric precision drug delivery devices.